SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001108205-24-000033
Filing Date
2024-05-07
Accepted
2024-05-07 08:30:21
Documents
60
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q cris-20240331.htm   iXBRL 10-Q 671339
2 EX-31.1 cris-3312024x10qexx311.htm EX-31.1 10808
3 EX-31.2 cris-3312024x10qexx312.htm EX-31.2 10762
4 EX-32.1 cris-3312024x10qexx321.htm EX-32.1 4742
5 EX-32.2 cris-3312024x10qexx322.htm EX-32.2 4689
  Complete submission text file 0001108205-24-000033.txt   4312724

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cris-20240331.xsd EX-101.SCH 35096
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cris-20240331_cal.xml EX-101.CAL 41970
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cris-20240331_def.xml EX-101.DEF 137209
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cris-20240331_lab.xml EX-101.LAB 500902
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cris-20240331_pre.xml EX-101.PRE 325010
64 EXTRACTED XBRL INSTANCE DOCUMENT cris-20240331_htm.xml XML 457332
Mailing Address 128 SPRING STREET BUILDING C, SUITE 500 LEXINGTON MA 02421
Business Address 128 SPRING STREET BUILDING C, SUITE 500 LEXINGTON MA 02421 617-503-6500
CURIS INC (Filer) CIK: 0001108205 (see all company filings)

IRS No.: 043505116 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-30347 | Film No.: 24919774
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)